US2023137154A1PendingUtilityA1
Reduced leaching of a ligand
Est. expiryOct 1, 2040(~14.2 yrs left)· nominal 20-yr term from priority
A61M 1/3679C07K 14/525B01J 2220/445B01J 20/3229C07K 14/7151B01J 20/3274A61M 2202/0445B01J 2220/58A61M 2205/3334B01J 20/321B01J 20/3212B01J 2220/603B01J 20/3219B01J 20/28052B01J 20/3285B01D 15/26B01J 20/28085B01J 20/267B01J 20/328A61M 1/0281B01J 20/327B01J 20/3085A61M 1/3472
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A column for removal of a component from a fluid is disclosed. The column has a compartment with a cross sectional area. The compartment contains beads having a diameter. A ligand selected to bind to the component is coupled to the beads. The cross-sectional area and bead diameter are selected to maintain a flow velocity of the fluid within the compartment below a first threshold, thereby reducing leaching of the ligand into the fluid. Also described herein is an adsorbent comprising a ligand that is attached to a substrate by an amine bond, wherein the ligand is resistant to dissociation from the substrate.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A column for removal of a component from a fluid, the column comprising:
a compartment comprising a cross-sectional area; a bead having a diameter and disposed within the compartment; and a ligand coupled to the bead and selected to bind to the component;
wherein the cross-sectional area and bead diameter are selected to maintain a flow velocity of the fluid within the compartment below a first threshold.
2 . The column of claim 1 , wherein the bead comprises a plurality of ligands.
3 . The column of claim 2 , wherein the ligand comprises a portion of Tumor Necrosis Factor alpha (TNF-alpha).
4 . The column of claim 3 , wherein the ligand comprises a trimer of the portions of TNF-alpha.
5 . The column of claim 1 , wherein the first threshold is selected so as to maintain an amount of the ligand in the fluid flowing out of the outlet below a predetermined level.
6 . The column of claim 1 , wherein the first threshold is selected so as to maintain a force applied by the fluid to the ligand below a second threshold, thereby reducing leaching of the ligand into the fluid.
7 . The column of claim 6 , wherein:
the ligand comprises a bond having a strength; and maintaining the force below the second threshold avoids breaking the bond.
8 . The column of claim 7 , wherein:
the bead comprises agarose; and the bond comprises an amine bond.
9 . The column of claim 6 , wherein:
the force comprises one or more of a shear force and a moment; and the second threshold comprises one or more of a third threshold related to the shear force and a fourth threshold related to the moment.
10 . The column of claim 1 , wherein:
the compartment further comprises an inlet, an outlet, and a flow path from the inlet to the outlet; the flow path has a length; and the length is selected to provide a contact time between the fluid and the ligand.
11 . The column of claim 1 , wherein:
the bead comprises a plurality of beads; and the ligand comprises a plurality of portions of ligand respectively coupled to each of the plurality of beads.
12 . The column of claim 1 , wherein the ligand is non-detachably coupled to the beads.
13 . A ligand for removal of a component from a fluid, the ligand comprising:
at least two monomers each comprising a site that will couple to the component; a first linker coupled by chemical bonds between two of the monomers; and a second linker coupled by chemical bonds between one of the monomers and a substrate.
14 . The ligand of claim 13 , wherein the ligand comprises three and only three monomers.
15 . The ligand of claim 13 , wherein the ligand comprises two and only two first linkers.
16 . The ligand of claim 13 , wherein the ligand comprises one and only one second linker.
17 . The ligand of claim 16 , wherein the second linker comprises an amine bond.
18 . The ligand of claim 13 , wherein the monomer comprises a site that will bind to a cytokine receptor.
19 . The ligand of claim 13 , wherein the monomer comprises tumor necrosis factor alpha (TNF-alpha).
20 . A column for use in removing a component from a fluid, the column comprising:
a compartment; a bead disposed within the compartment, the bead comprising:
a substrate; and
a ligand coupled to the substrate, the ligand comprising:
at least two monomers each comprising a site that will couple to the component;
a first linker coupled by chemical bonds between two of the monomers; and
a second linker coupled by chemical bonds between one of the monomers and the substrate.
21 . A method of preparing an apheresis particle, comprising the steps of:
oxidizing a substrate; forming a Schiff base between a ligand comprising a portion of Tumor Necrosis Factor alpha (TNF-alpha) and the oxidized substrate; and converting the Schiff base to a secondary amine bond.
22 . The method of claim 21 , wherein the step of oxidizing a substrate comprises exposing the substrate to an inorganic salt.
23 . The method of claim 22 , wherein the inorganic salt comprises sodium metaperiodate.
24 . The method of claim 21 , wherein the step of converting the Schiff base to a secondary amine bond comprises exposing the substrate to a reducing agent.
25 . The method of claim 24 , wherein the reducing agent comprises sodium cyanoborohydride.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.